EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Programmed cell death in dementia: advances in pathogenesis and therapeutic strategies

Sisi Yu, Zheng Luo, Shuhui Wan, Mu Li, Cheng Li, Gui Xiao

Frontiers in Cell and Developmental Biology · 10.11.2026 · 14

DOI: 10.3389/fcell.2026.1989495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 10.11.2026. Verfasst von Sisi Yu und 5 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Jiangxi Provincial Association of Social Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dementia comprises a group of neurodegenerative disorders characterized primarily by progressive cognitive decline. Its central pathological feature is the irreversible loss of neurons, which leads to the continuous deterioration of memory, language, and executive functions. In recent years, programmed cell death (PCD), as a major form of regulated cell death, has attracted increasing attention because of its critical involvement in neuronal loss during the development of dementia. Accumulating evidence has demonstrated that multiple forms of PCD, including apoptosis, autophagic cell death, necroptosis, pyroptosis, and ferroptosis, are aberrantly activated in common dementia subtypes such as Alzheimer’s disease (AD) and vascular dementia (VaD), where they synergistically promote neurodegeneration through distinct molecular mechanisms. However, therapeutic interventions targeting a single PCD pathway are often insufficient to halt disease progression, and the pathological heterogeneity among different dementia subtypes further complicates treatment. This review systematically summarizes the molecular mechanisms and pathological contributions of the major forms of PCD in dementia and further discusses emerging therapeutic strategies targeting PCD pathways, including small-molecule inhibitors, genetic modulation, and nanomedicine-based drug delivery systems. By integrating recent advances in this field, this review aims to provide a theoretical framework and translational perspectives for the development of early diagnostic biomarkers and precision therapeutic strategies for dementia.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Jiangxi Provincial Association of Social Sciences

Zitieren

APA

Yu, S., Luo, Z., Wan, S., Li, M., Li, C., & Xiao, G. (2026). Programmed cell death in dementia: advances in pathogenesis and therapeutic strategies. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1989495

Vancouver

Yu S, Luo Z, Wan S, Li M, Li C, Xiao G. Programmed cell death in dementia: advances in pathogenesis and therapeutic strategies. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1989495

BibTeX
@article{Yu2026,
  author = {Yu, Sisi and Luo, Zheng and Wan, Shuhui and Li, Mu and Li, Cheng and Xiao, Gui},
  title = {Programmed cell death in dementia: advances in pathogenesis and therapeutic strategies},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1989495}
}
Kostenlos starten →